Trial
NCT04003818
Efficacy and Safety of Teicoplanin in CDAD
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
—
Condition
Clostridium Difficile Infection-associated Diarrhea and Colitis
Intervention
TEICOPLANIN
Why stopped
Due to COVID-19 and great challenges during patient enrolment period, current status of this study is far behind the plan. The study cannot be completed according to the plan. Sanofi decides to terminate the study upon comprehensive assessment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-23